1 September 2024
Starpharma raises $1.9M under Share Purchase Plan
Melbourne, Australia; 20 January 2016: Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today announced it has completed its Share Purchase Plan (SPP) having raised approximately $1.9 million. Combining the SPP with the recent institutional placement which raised $32 million (before costs); the Company has successfully raised a total of approximately $34 million at $0.73 per share.
Starpharma Chief Executive Officer Dr Jackie Fairley said: “We thank our shareholders for their ongoing strong support of the Company. We are very pleased to have such excellent support from both new and existing institutional investors, and retail shareholders. The near $34 million total raised positions us very well for the acceleration of our development and commercialization programs for drug delivery, VivaGel®, and agrochemicals.”
All eligible (Australian) directors took up the full $15,000 allocation under the SPP.
Download ASX Announcement: Starpharma raises $1.9M under Share Purchase Plan ( pdf file, 91kb)